3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Active not recruiting
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Breast Neoplasms
6
Sarcoma
4
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Glioblastoma
2
Endometrial Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Meningioma
1
Male Urogenital Diseases
1
Lung Neoplasms
1
Locally Recurrent Rectal Cancer
1
Head and Neck Neoplasms
1
Female Urogenital Diseases
1
Interventions
Cisplatin
22
pembrolizumab
21
Carboplatin
12
Radiotherapy
11
Paclitaxel
11
Brachytherapy
11
Drug Therapy
10
Bevacizumab
9
Blood Specimen Collection
7
Colposcopy
6
Specimen Handling
5
Injections
5
toripalimab
4
Taxes
4
Surveys and Questionnaires
4
Nivolumab
4
Mass Screening
4
Human Papillomavirus DNA Tests
4
Gemcitabine
4
Chemotherapy, Adjuvant
4
Chemoradiotherapy
4
spartalizumab
3
lenvatinib
3
camrelizumab
3
aldesleukin
3
Restraint, Physical
3
Radiation
3
Fulvestrant
3
Cyclophosphamide
3
Biopsy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Uterine Cervical Neoplasms
×
Radiation Dose Hypofractionation
×
Clear all
NCT07595224
2026-05-19
PostOP HYPOCxE
Siriraj Hospital
Phase NA
Recruiting
120 enrolled
NCT07276360
2026-03-27
HypoRTCx-UG
Uganda Cancer Institute
Phase 2
Recruiting
278 enrolled